Search

Displaying results 9761 - 9770 of 10000 in total
  1. Drug

    TEL540-548

    go.drugbank.com/drugs/DB17461
    Investigational

    TEL540-548 is a recombinant peptide consisting of the amino acid residues 540 to 548 of the human telomerase reverse transcriptase (hTERT).

  2. Drug

    Rogaratinib

    go.drugbank.com/drugs/DB15078
    Investigational

    Rogaratinib is under investigation in clinical trial NCT03762122 (Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)).

  3. Drug

    Tidiacic arginine

    go.drugbank.com/drugs/DB13748
    Experimental

    Categories: Bile and Liver Therapy, Alimentary Tract and Metabolism
  4. Drug

    Arpraziquantel

    go.drugbank.com/drugs/DB11749
    Investigational

    (R)-Praziquantel is under investigation in clinical trial NCT02271984 (Relative Bioavailability Trial of L-Praziquantel in Healthy Volunteers).

    Categories: Quinoline Derivatives and Related Substances, Antiparasitic Products, Insecticides and Repellents
  5. Drug

    Opebacan

    go.drugbank.com/drugs/DB06161
    Investigational

  6. Drug

    AVI-4020

    go.drugbank.com/drugs/DB05873
    Investigational

    AVI-4020 is a neugene antisense drug candidate for the treatment of patients with acute West Nile virus disease who have serious neurological impairment (WNV neuroinvasive disease).

  7. Drug

    Benzoxonium

    go.drugbank.com/drugs/DB13565
    Experimental

    Categories: Alimentary Tract and Metabolism, Antiseptics and Disinfectants
  8. Drug

    Chlormadinone

    go.drugbank.com/drugs/DB13528
    Investigational

    Categories: chlormadinone and estrogen, chlormadinone and ethinylestradiol
  9. Drug

    Latrunculin B

    go.drugbank.com/drugs/DB08080
    Experimental

    Latrunculin B is a 14-membered macrolide attached to 2-thiazolidinone moiety, isolated from Red Sea sponge _Latrunculia magnifica_.

  10. Drug

    TC-6987

    go.drugbank.com/drugs/DB14854
    Investigational

    TC-6987 is under investigation in clinical trial NCT01296087 (TC-6987 for the Treatment of Mild to Moderate Asthma).